Becton Dickinson Share Holder Equity 2012-2026 | BDX
Becton Dickinson share holder equity from 2012 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
- Becton Dickinson share holder equity for the quarter ending March 31, 2026 was $25.282B, a 0.31% increase year-over-year.
- Becton Dickinson share holder equity for 2025 was $25.39B, a 1.93% decline from 2024.
- Becton Dickinson share holder equity for 2024 was $25.89B, a 0.36% increase from 2023.
- Becton Dickinson share holder equity for 2023 was $25.796B, a 2.03% increase from 2022.
|
Becton Dickinson Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $25,390 |
| 2024 | $25,890 |
| 2023 | $25,796 |
| 2022 | $25,282 |
| 2021 | $23,677 |
| 2020 | $23,765 |
| 2019 | $21,081 |
| 2018 | $20,994 |
| 2017 | $12,948 |
| 2016 | $7,633 |
| 2015 | $7,164 |
| 2014 | $5,053 |
| 2013 | $5,043 |
| 2012 | $4,136 |
| 2011 | $4,828 |
|
Becton Dickinson Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-12-31 | $25,282 |
| 2025-09-30 | $25,390 |
| 2025-06-30 | $25,472 |
| 2025-03-31 | $25,241 |
| 2024-12-31 | $25,205 |
| 2024-09-30 | $25,890 |
| 2024-06-30 | $25,868 |
| 2024-03-31 | $25,647 |
| 2023-12-31 | $25,332 |
| 2023-09-30 | $25,796 |
| 2023-06-30 | $25,937 |
| 2023-03-31 | $25,689 |
| 2022-12-31 | $25,472 |
| 2022-09-30 | $25,282 |
| 2022-06-30 | $25,493 |
| 2022-03-31 | $24,525 |
| 2021-12-31 | $24,160 |
| 2021-09-30 | $23,677 |
| 2021-06-30 | $24,135 |
| 2021-03-31 | $24,826 |
| 2020-12-31 | $24,663 |
| 2020-09-30 | $23,765 |
| 2020-06-30 | $24,022 |
| 2020-03-31 | $20,951 |
| 2019-12-31 | $21,202 |
| 2019-09-30 | $21,081 |
| 2019-06-30 | $21,497 |
| 2019-03-31 | $21,309 |
| 2018-12-31 | $21,404 |
| 2018-09-30 | $20,994 |
| 2018-06-30 | $21,357 |
| 2018-03-31 | $21,152 |
| 2017-12-31 | $21,247 |
| 2017-09-30 | $12,948 |
| 2017-06-30 | $12,587 |
| 2017-03-31 | $7,963 |
| 2016-12-31 | $7,583 |
| 2016-09-30 | $7,633 |
| 2016-06-30 | $8,033 |
| 2016-03-31 | $7,666 |
| 2015-12-31 | $7,223 |
| 2015-09-30 | $7,164 |
| 2015-06-30 | $7,253 |
| 2015-03-31 | $7,159 |
| 2014-12-31 | $5,068 |
| 2014-09-30 | $5,053 |
| 2014-06-30 | $5,378 |
| 2014-03-31 | $5,315 |
| 2013-12-31 | $5,078 |
| 2013-09-30 | $5,043 |
| 2013-06-30 | $4,717 |
| 2013-03-31 | $4,589 |
| 2012-12-31 | $4,469 |
| 2012-09-30 | $4,136 |
| 2012-06-30 | $4,235 |
| 2012-03-31 | $4,476 |
| 2011-12-31 | $4,728 |
| 2011-09-30 | $4,828 |
| 2011-06-30 | $5,298 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |